Blog

Preparation for ketamine-assisted psychotherapy (KAP) involves several key components aimed at ensuring the safety and efficacy of the treatment, as well as preparing the patient mentally and emotionally for the experience. Keep reading.

In recent years, ketamine-assisted psychotherapy (KAP) has emerged as a promising treatment for various mental health conditions, offering new hope to individuals who have not found relief through conventional therapies. Learn more.

New research found a connection between the gut microbiome and Alzheimer's disease. Dr. David Merrill offers his insights on these findings.

Ketamine-assisted psychotherapy (KAP) is emerging as a significant therapeutic approach for various mental health conditions. However, the efficacy of KAP is greatly enhanced when coupled with a crucial component: integration. Learn how Pacific Neuroscience Institute® (PNI®)'s Treatment & Research in Psychedelics (TRIP) Center uses integration to optimize patient outcomes.

Explore the transformative benefits of ketamine therapy in treating treatment-resistant depression, anxiety disorders, PTSD, chronic pain, and addiction. Learn how Pacific Neuroscience Institute's expert team harnesses the potential of ketamine to offer hope and relief.

Discover Demi Lovato's journey with bipolar disorder, with expert insight from David Merrill, MD, PhD, director of the Pacific Brain Health Center. Learn why celebrities like her sharing their mental health challenges is essential to destigmatize conditions and encourage seeking help. Explore the importance of proper diagnosis and treatment for mental health conditions. Join the conversation about breaking the stigma surrounding mental health.

Immersive nature videos may enhance psychedelic-assisted therapy for alcohol addiction, according to research by Pacific Neuroscience Institute and renowned filmmaker Louie Schwartzberg.

We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.

Discover the transformative power of psychedelics for treating traumatic brain injuries (TBI) and mental health conditions. Witness former UFC fighter Ian McCall's inspiring recovery using psilocybin mushrooms. Join the conversation on revolutionizing mental health treatment with Daniel F. Kelly, MD, CEO of Pacific Neuroscience Institute (PNI) and board-certified neurosurgeon.

This episode comes from the Saint John’s Health Center Foundation’s podcast, Your Daily Dose with Kym Douglas. Pacific Neuroscience Institute experts, Dr. Keith Heinzerling and Dr. Daniel Kelly discuss the Treatment & Research in Psychedelics (TRIP) program at PNI. Dr. Heinzerling, an addiction medicine specialist and TRIP director, and Dr. Kelly, director and one of the four founders of PNI describe how psychedelic-assisted therapy with compounds such as psilocybin from “magic mushrooms” in clinical trials can help treat conditions such as alcohol use disorder, anxiety, and depression. Listen to this episode to learn how these doctors envision psychedelic-assisted therapy transforming the current model of mental health care.